XOMA Royalty Corp files 425

Ligand Pharmaceuticals Incorporated is acquiring XOMA Royalty Corporation through a merger. XOMA Royalty shareholders will receive $39.00 in cash and one contingent value right (CVR) per share. The headline deal value is not explicitly stated as a single aggregate figure in the provided text.